Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
1992-12-15
pubmed:abstractText
Levels of human immunodeficiency virus (HIV) DNA, RNA, or p24 antigen and reverse transcriptase activity in T-cell cultures treated with 500 IU of recombinant alpha interferon (rIFN alpha) per ml were comparable to those in control cultures. Radioimmunoprecipitation analysis of proteins in lysates of IFN-treated T cells documented a marked accumulation of HIV proteins. Localization of gp120 by immunofluorescence showed a diffuse pattern in IFN-treated cells quite distinct from the ring pattern in untreated control cells. That large quantities of gp120 in aberrant cell compartments might affect HIV morphogenesis was confirmed in infectivity studies: virions from IFN-treated cells were 100- to 1,000-fold less infectious than an equal number of virions from control cells. Direct examination of IFN-treated and control HIV-infected cells by transmission electron microscopy showed little difference in the number or distribution of viral particles. However, quantitation of gp120 by immunogold particle analysis revealed a marked depletion of envelope glycoprotein in virions released from IFN-treated cells. This defect in gp120 assembly onto mature viral particles provides a molecular basis for this loss of infectivity.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/1279206-1573317, http://linkedlifedata.com/resource/pubmed/commentcorrection/1279206-1686880, http://linkedlifedata.com/resource/pubmed/commentcorrection/1279206-1688522, http://linkedlifedata.com/resource/pubmed/commentcorrection/1279206-1707604, http://linkedlifedata.com/resource/pubmed/commentcorrection/1279206-1710293, http://linkedlifedata.com/resource/pubmed/commentcorrection/1279206-1711253, http://linkedlifedata.com/resource/pubmed/commentcorrection/1279206-1715409, http://linkedlifedata.com/resource/pubmed/commentcorrection/1279206-1738192, http://linkedlifedata.com/resource/pubmed/commentcorrection/1279206-1906289, http://linkedlifedata.com/resource/pubmed/commentcorrection/1279206-1971503, http://linkedlifedata.com/resource/pubmed/commentcorrection/1279206-1976701, http://linkedlifedata.com/resource/pubmed/commentcorrection/1279206-2213506, http://linkedlifedata.com/resource/pubmed/commentcorrection/1279206-227998, http://linkedlifedata.com/resource/pubmed/commentcorrection/1279206-2364019, http://linkedlifedata.com/resource/pubmed/commentcorrection/1279206-2415251, http://linkedlifedata.com/resource/pubmed/commentcorrection/1279206-2461053, http://linkedlifedata.com/resource/pubmed/commentcorrection/1279206-2470148, http://linkedlifedata.com/resource/pubmed/commentcorrection/1279206-2849111, http://linkedlifedata.com/resource/pubmed/commentcorrection/1279206-3058820, http://linkedlifedata.com/resource/pubmed/commentcorrection/1279206-3260631, http://linkedlifedata.com/resource/pubmed/commentcorrection/1279206-3481357, http://linkedlifedata.com/resource/pubmed/commentcorrection/1279206-6154948, http://linkedlifedata.com/resource/pubmed/commentcorrection/1279206-6180108, http://linkedlifedata.com/resource/pubmed/commentcorrection/1279206-6186764, http://linkedlifedata.com/resource/pubmed/commentcorrection/1279206-6244697, http://linkedlifedata.com/resource/pubmed/commentcorrection/1279206-6302994, http://linkedlifedata.com/resource/pubmed/commentcorrection/1279206-6410234, http://linkedlifedata.com/resource/pubmed/commentcorrection/1279206-7119475, http://linkedlifedata.com/resource/pubmed/commentcorrection/1279206-79409, http://linkedlifedata.com/resource/pubmed/commentcorrection/1279206-85689, http://linkedlifedata.com/resource/pubmed/commentcorrection/1279206-88939
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0022-538X
pubmed:author
pubmed:issnType
Print
pubmed:volume
66
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
7543-8
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed:year
1992
pubmed:articleTitle
Loss of infectivity by progeny virus from alpha interferon-treated human immunodeficiency virus type 1-infected T cells is associated with defective assembly of envelope gp120.
pubmed:affiliation
Department of Cellular Immunology, Walter Reed Army Institute of Research, Washington, D.C. 20307-5100.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't